<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> (MDSs) are a <z:hpo ids='HP_0001425'>heterogeneous</z:hpo> group of clonal haematological diseases characterized by ineffective haematopoiesis and predisposition to <z:hpo ids='HP_0011009'>acute</z:hpo> <z:mpath ids='MPATH_342'>myeloid leukaemia</z:mpath> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>The pathophysiology of MDSs remains unclear </plain></SENT>
<SENT sid="2" pm="."><plain>A definition of the molecular biology of MDSs may lead to a better classification, new prognosis indicators and new treatments </plain></SENT>
<SENT sid="3" pm="."><plain>We studied a series of 40 MDS/AML samples by high-density array-comparative genome hybridization (aCGH) </plain></SENT>
<SENT sid="4" pm="."><plain>The genome of MDSs displayed a few alterations that can point to candidate genes, which potentially regulate <z:chebi fb="0" ids="15358">histone</z:chebi> modifications and WNT pathways (e.g. ASXL1, ASXL2, UTX, CXXC4, CXXC5, TET2, TET3) </plain></SENT>
<SENT sid="5" pm="."><plain>To validate some of these candidates we studied the sequence of ASXL1 </plain></SENT>
<SENT sid="6" pm="."><plain>We found mutations in the ASXL1 gene in four out of 35 MDS patients (11%) </plain></SENT>
<SENT sid="7" pm="."><plain>To extend these results we searched for mutations of ASXL1 in a series of <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:mpath ids='MPATH_501'>myelomonocytic leukaemias</z:mpath>, a disease classified as <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>/<z:hpo ids='HP_0005547'>Myeloproliferative disorder</z:hpo>, and found mutations in 17 out of 39 patients (43%) </plain></SENT>
<SENT sid="8" pm="."><plain>These results show that ASXL1 might play the role of a <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> suppressor in <z:e sem="disease" ids="C0027022" disease_type="Neoplastic Process" abbrv="MPD">myeloid malignancies</z:e> </plain></SENT>
</text></document>